Thrombolytic therapy for myocardial infarction [2] (multiple letters)

New England Journal of Medicine

Volumn 338, Issue 8, 1998, Pages 545-548

  Frei, S ^a   Brophy, J ^a   Andreotti, F ^a   Thron, C D ^a   Topol, E J ^a   Califf, R M ^a   Wilcox, R ^a   Van de Werf, F ^a   Ware, J H ^a   Antman, E M ^a  

^a Sacred Heart Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; RETEPLASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR; RECOMBINANT PROTEIN;

ANXIETY NEUROSIS; CATECHOLAMINE RELEASE; DOSE RESPONSE; HEART INFARCTION; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT PLANNING; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; EPIDEMIOLOGY; FIBRINOLYTIC THERAPY; HUMAN; METHODOLOGY; NOTE; OUTCOME ASSESSMENT; PHARMACOKINETICS;

BIAS (EPIDEMIOLOGY); DOUBLE-BLIND METHOD; HUMANS; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATORS; RECOMBINANT PROTEINS; RESEARCH DESIGN; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; OUTCOME ASSESSMENT (HEALTH CARE); THERAPEUTIC EQUIVALENCY;

EID: 0032545913     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199802193380811     Document Type: Letter

References (0)